Notably, KRAS exhibits the highest frequency of mutations in Pancreatic Adenocarcinoma (PAAD), followed by Colon Adenocarcinoma (COAD) and Lung Adenocarcinoma (LUAD), which are also tumor types that garner considerable attention from the cancer research community1,4. This evidence concerns the gene KRAS and cancer.